Lupartumab (BAY 1112623) is a monoclonal antibody targeting LYPD3 (C4.4A) and is employed in the synthesis of antibody-active molecular couplers for studying LYPD3-associated tumor diseases.
Purity:
97.45%
CAS Number:
[1640971-88-5]
Target:
ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted